For example, GIP analogues that do not alter bodyweight when administered alone to mice with diet‐induced obesity were found to enhance GLP‐1‐induced weight loss, reduce food intake, and prevent fat mass accumulation126, 127; however, similar results have also been obtained with GIP antibodies.128. Here, GLP1R is linked to Obesity.